Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thezenas

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 24, 2020
Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective studyMathias Neron, Eric Lambaudie, Simon Thezenas, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Clinical Breast Cancer|April 3, 2026
Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort StudiesEvan Cescon, Pamela Goodwin, Angelique Bobrie, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2006
Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic resultsClaire Lemanski, David Azria, Simon Thezenas, et al.
Pancreas|November 1, 2002
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatinDavid Azria, Marc Ychou, William Jacot, et al.
World Journal of Gastroenterology|April 12, 2012
Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancerRomain Altwegg, Marc Ychou, Vanessa Guillaumon, et al.
Clinical and Translational Medicine|May 19, 2015
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancerMounira El Demery, Gaiané Demirdjian-Sarkissian, Simon Thezenas, et al.
BMC Cancer|August 1, 2018
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective studyMarie Viala, Akiko Chiba, Simon Thezenas, et al.
Clinical Chemistry|August 12, 2022
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective StudyAmélie Darlix, Laure Cayrefourcq, Stéphane Pouderoux, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 26, 2018
Assessing dietary intake in accordance with guidelines: Useful correlations with an ingesta-Verbal/Visual Analogue Scale in medical oncology patientsEstelle Guerdoux-Ninot, Nicolas Flori, Chloé Janiszewski, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 24, 2020
Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective studyMathias Neron, Eric Lambaudie, Simon Thezenas, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Clinical Breast Cancer|April 3, 2026
Plasma Hepcidin as a Prognostic Biomarker in Obese and Nonobese Patients With Early Breast Cancer: A Pooled Analysis of Two Prospective Cohort StudiesEvan Cescon, Pamela Goodwin, Angelique Bobrie, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2006
Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic resultsClaire Lemanski, David Azria, Simon Thezenas, et al.
Pancreas|November 1, 2002
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatinDavid Azria, Marc Ychou, William Jacot, et al.
World Journal of Gastroenterology|April 12, 2012
Second-line therapy for gemcitabine-pretreated advanced or metastatic pancreatic cancerRomain Altwegg, Marc Ychou, Vanessa Guillaumon, et al.
Clinical and Translational Medicine|May 19, 2015
Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancerMounira El Demery, Gaiané Demirdjian-Sarkissian, Simon Thezenas, et al.
BMC Cancer|August 1, 2018
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective studyMarie Viala, Akiko Chiba, Simon Thezenas, et al.
Clinical Chemistry|August 12, 2022
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective StudyAmélie Darlix, Laure Cayrefourcq, Stéphane Pouderoux, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 26, 2018
Assessing dietary intake in accordance with guidelines: Useful correlations with an ingesta-Verbal/Visual Analogue Scale in medical oncology patientsEstelle Guerdoux-Ninot, Nicolas Flori, Chloé Janiszewski, et al.
Pageof 6